Prime Capital Investment Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-452
| Closed | -$69K | – | 575 |
|
|
2021
Q1 | $69K | Sell |
452
-348
| -44% | -$53.1K | 0.01% | 311 |
|
|
2020
Q4 | $125K | Sell |
800
-150
| -16% | -$23.4K | 0.01% | 263 |
|
|
2020
Q3 | $109K | Hold |
950
| – | – | 0.01% | 274 |
|
|
2020
Q2 | $107K | Sell |
950
-9
| -0.9% | -$1.01K | 0.01% | 273 |
|
|
2020
Q1 | $86K | Buy |
959
+252
| +36% | +$22.6K | 0.01% | 255 |
|
|
2019
Q4 | $76K | Sell |
707
-400
| -36% | -$43K | 0.01% | 270 |
|
|
2019
Q3 | $108K | Buy |
1,107
+557
| +101% | +$54.3K | 0.02% | 241 |
|
|
2019
Q2 | $72K | Hold |
550
| – | – | 0.01% | 222 |
|
|
2019
Q1 | $74K | Buy |
+550
| New | +$74K | 0.02% | 173 |
|